![]() |
|
October 25, 2009 to October 31, 2009 (Week 43) |
Posted 2009-11-06
Summary of FluWatch Findings for the
Week ending October 31, 2009
A total of 2,440 hospitalized cases including 443 cases admitted to ICU and 230 cases required ventilation as well as 100 deaths of Pandemic (H1N1) 2009 were reported to PHAC as of October 31, 2009. Since the beginning of the pandemic (April 12, 2009 to October 31, 2009), the national cumulative crude hospitalization rate is 7.3 per 100,000 population and the national cumulative crude mortality rate is 0.3 per 100,000 population. In addition, the national cumulative crude ICU admission and ventilation rates are 1.3 and 0.7 per 100,000 population, respectively. This week’s report provides comparisons of current data and data reported since August 30, 2009 up to October 31, 2009 which can be used as the baseline comparison period (see table below).
Since August 30 up to October 31, 2009, the national crude hospitalization rate is 2.8 per 100,000 population and the national cumulative crude mortality rate is 0.1 per 100,000 population. In addition, the national cumulative crude ICU admission is 0.4 per 100,000 population. This week, October 25 to 31, 2009, the national crude hospitalization rate is 2.0 per 100,000 population and the national cumulative crude mortality rate is 0.02 per 100,000 population. In addition, the national cumulative crude ICU admission is 0.3 per 100,000 population.
There was a considerable increase in the number of hospitalizations and deaths reported during the last week with QC, BC, and ON reporting the highest numbers. The numbers reported during the previous weeks were similar to the peak period of the first wave (e.g. the three first weeks of June, 2009). The greatest numbers of ICU admissions were reported from QC, BC, and AB. Deaths occurred in ON (3), BC (2), AB (2), and NL (1). Since August 30 up to October 31, 2009, the proportion of females affected, the median age and the proportion of cases with underlying medical conditions was still increasing with severity of illness (see Characteristics table). Comparing the period of up to August 29, 2009 to the period of August 30, 2009 to October 31, 2009, less pregnant women among women of reproductive age and less Aboriginals were hospitalized, admitted to ICU and died during the period ending October 31, 2009.
| Province/Territory | This week (Oct. 25-31, 2009)* | From
August 30, 2009 to October 31, 2009** |
From April to August 29, 2009** | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Hospitalized cases | ICU admissions | Deaths | Hospitalized cases | ICU admissions | Deaths | Hospitalized cases | ICU admissions | Deaths | |
| BC1 | 162 | 22 | 2 | 307 | 52 | 9 | 54 | 21 | 5 |
| AB | 80 | 19 | 2 | 126 | 25 | 6 | 137 | 33 | 8 |
| SK | 3 | 3 | 0 | 4 | 3 | 1 | 23 | 12 | 4 |
| MB | 0 | 0 | 0 | 0 | 0 | 0 | 227 | 43 | 7 |
| ON | 105 | 13 | 3 | 166 | 26 | 7 | 378 | 67 | 23 |
| QC | 246 | 30 | 0 | 261 | 32 | 0 | 572 | 104 | 27 |
| NB | 5 | 0 | 0 | 1 | 0 | 0 | 7 | 1 | 0 |
| NS | 16 | 3 | 0 | 15 | 3 | 0 | 18 | 8 | 1 |
| PE | 3 | 0 | 0 | 3 | 0 | 0 | 1 | 0 | 0 |
| NL1 | 27 | 0 | 1 | 27 | 0 | 1 | 3 | 1 | 0 |
| YT | 4 | 1 | 0 | 4 | 1 | 0 | 0 | 0 | 0 |
| NT | 10 | 2 | 0 | 34 | 5 | 0 | 6 | 0 | 0 |
| NU | 0 | 0 | 0 | 0 | 0 | 0 | 66 | 6 | 1 |
| Canada | 661 | 93 | 8 | 948 | 147 | 24 | 1492 | 296 | 76 |
| *Based on reporting date. ** Based on epidemiological date. 1 These two provinces reported aggregate counts this week. |
|||||||||
| 1 Proportion of cases with at least one underlying medical condition (excluding pregnancy) among those for whom the information was available. Note that P/T are now reporting on three additional underlying medical conditions: chronic liver disease, chronic neurological disease and anemia or hemoglobinopathy. 2 Percent of pregnant women among women 15 to 44 years of age. |
||||||
| From August 30, 2009 to October 31, 2009 | From April to August 29, 2009 | |||||
|---|---|---|---|---|---|---|
| Hospitalized cases (n=854) |
Cases admitted to ICU (n=147) |
Deaths (n=24) |
Hospitalized cases (n=1,492) |
Cases admitted to ICU (n=296) |
Deaths (n=76) |
|
| Females, % | 52.1 | 54.4 | 54.2 | 51.4 | 57.4 | 60.5 |
| Median age | 25.0 | 44.0 | 48.0 | 23.0 | 37.0 | 51.0 |
| Aboriginal status, % | 5.5 | 4.1 | 8.3 | 17.8 | 14.9 | 11.8 |
| Underlying medical conditions1 , % | 57.1 (208/364) |
68.5 (61/89) |
76.9 (10/13) |
55.9 (469/839) |
67.8 (122/180) |
73.9 (34/46) |
| Pregnancy2 , % | 19.3 (33/171) | 9.7 (3/31) | 0.0 | 22.7 (63/277) | 14.1 (11/78) | 28.6 (4/14) |
Considerable increases in overall influenza activity were reported this week. All indicators (proportion of positive influenza tests, national ILI consultation rate, number of regions reporting widespread activity and number of influenza outbreaks) were considerably higher this week compared to the previous weeks.
Nineteen regions reported widespread activity in BC, AB, SK, ON, NL & NT and sixteen regions in ON, QC, NB, NS, PEI & YK reported localized activity, while eighteen regions reported sporadic activity in MB, QC, NB, NS, NL & NU and one region in NB reported no activity. The 737 influenza outbreaks reported this week were all in schools except 11 in hospitals (NL, ON), 9 in an unspecified location (AB, ON, NL & YK) and 7 in long-term care facility (BC, SK, QC & NL). The schools outbreaks were in AB (361), BC (146), SK (105), NS (66), PEI (16), NB (11), NL (3) and NT (2). Note that this is the first year that all the provinces and territories are reporting on influenza outbreaks in schools (greater than 10% absenteeism on any day most likely due to ILI) which is increasing considerably the total number of outbreaks reported compared to the previous years.
![]() |
|
Note: Influenza activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates (see graphs and tables) and reported outbreaks. Please refer to detailed definitions on the last page. For areas where no data is reported, late reports from these provinces and territories will appear on the FluWatch website.

![]()
† sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in.

![]()
ILI consultation rate
This week, the national ILI consultation rate was 111 consultations per 1,000 patient visits (see ILI graph) which is significantly higher compared to the previous weeks and still highly above the expected range for this time of the year. All provinces and territories had higher ILI consultation rates compared to last week except for BC, SK, YK and NT which had similar rates in comparison to the previous week. People under 20 years of age had the highest consultations rates with 293 and 239 per 1,000 patient visits among children under 5 years of age and among those 5 and 19 years of age, respectively.

![]()
Note: No data available for mean rate in previous years for weeks 19 to 39 (1996-1997 through 2002-2003 seasons).
*Delays in the reporting of data may cause data to change restrospectively.
Paediatric Influenza Hospitalizations and deaths
In week 43, 120 laboratory-confirmed influenza-associated paediatric hospitalizations were reported through the Immunization Monitoring Program Active (IMPACT) network. 116 Pandemic (H1N1) 2009 and 4 other hospitalizations due to unsubtyped influenza A were reported this week. 605 hospitalizations had been reported since week 17 (April 26); 95.2% of these hospitalizations were due to Pandemic (H1N1) 2009. Since the beginning of the pandemic, four deaths due to Pandemic (H1N1) 2009 had been reported through the IMPACT network among children under 16 years of age.
Laboratory Surveillance Summary
This week, the proportion of tests that were positive for influenza was 36.3% which is a significant increase compared to the previous weeks (see Tests table). All provinces and territories had a high proportion of positive tests for influenza this week, except British Columbia which had a slightly lower proportion this week. This week, the number of specimen tested positive for influenza was two times higher with 7,970 specimen (all A and 2 B) and the proportion of positive subtyped influenza A specimens that were Pandemic (H1N1) 2009 was 99.7%.

![]()

![]()
| Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Note: Cumulative data includes updates to previous weeks; due to reporting delays, the sum of weekly report totals do not add up to cumulative totals. * Not subtyped |
||||||||||||
| Reporting provinces | Weekly (Oct. 25-31, 2009) | Cumulative (Aug. 30-Oct. 31, 2009) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Influenza A | B | Influenza A | B | |||||||||
| A Total | A(H1) | A(H3) | Pand (H1N1) | A (NS)* | Total | A Total | A(H1) | A(H3) | Pand (H1N1) | A (NS)* | Total | |
| BC | 1243 | 0 | 1 | 1239 | 3 | 0 | 3891 | 0 | 1 | 3330 | 560 | 0 |
| AB | 2254 | 0 | 0 | 0 | 2254 | 0 | 4101 | 0 | 0 | 769 | 3332 | 0 |
| SK | 487 | 0 | 0 | 443 | 44 | 0 | 700 | 0 | 1 | 605 | 94 | 0 |
| MB | 53 | 0 | 0 | 37 | 16 | 0 | 93 | 0 | 0 | 71 | 22 | 0 |
| ON | 1501 | 1 | 1 | 665 | 834 | 1 | 2834 | 2 | 1 | 1442 | 1389 | 3 |
| QC | 1796 | 0 | 11 | 1785 | 0 | 1 | 2418 | 1 | 23 | 2394 | 0 | 1 |
| NB | 67 | 0 | 0 | 67 | 0 | 0 | 80 | 1 | 1 | 76 | 2 | 1 |
| NS | 244 | 0 | 0 | 241 | 3 | 0 | 331 | 0 | 0 | 318 | 13 | 0 |
| PE | 42 | 0 | 0 | 42 | 0 | 0 | 54 | 0 | 0 | 53 | 1 | 0 |
| NL | 283 | 0 | 0 | 283 | 0 | 0 | 360 | 0 | 0 | 360 | 0 | 0 |
| Canada | 7970 | 1 | 13 | 4802 | 3154 | 2 | 14862 | 4 | 27 | 9418 | 5413 | 5 |
During week 43, compared to other prescriptions filled in Canada, the sale of AV demonstrated an increase in prescription rates in all provinces and territories. From October 25 to October 31, 2009, the top five Health Regions in Canada, from highest to lowest antiviral prescription sales per all other prescription sales (antivirals/1,000 prescription sales) were in Western Newfoundland (88), Northern Alberta (66), Eastern Newfoundland (60), Northeastern British Columbia (56) and Eastern Ontario (49).

Reference: H1N1 Antiviral and OTC Surveillance Weekly Report. CFEZID, PHAC.
Antigenic Characterization
Since September 1, 2009, NML has antigenically characterized 69 Pandemic (H1N1) 2009 viruses and two seasonal influenza viruses (one influenza A/H1N1 and one B virus) that were received from Canadian laboratories. All 69 Pandemic influenza A (H1N1) viruses characterized were antigenically related to A/California/7/2009, which is the pandemic reference virus selected by WHO as Pandemic (H1N1) 2009 vaccine. The one seasonal influenza A/H1N1 virus characterized was related to A/Brisbane/59/07, which is the influenza A/H1N1 component recommended for the 2009-10 influenza vaccine. The one influenza B virus characterized was antigenically related to B/Brisbane/60/08, which is the recommended influenza B component for the 2009-10 influenza vaccine.
Antiviral Resistance
NML: Pandemic (H1N1) 2009 viruses tested so far have been sensitive to zanamivir (69 samples) but resistant to amantadine (52 samples). Of the 68 Pandemic (H1N1) 2009 viruses tested, 66 were sensitive to oseltamivir and two viruses were resistant to oseltamivir with the H275Y mutation. The two resistant cases were associated with oseltamivir treatment.
Provinces: Three cases of oseltamivir resistant Pandemic (H1N1) 2009 were reported to date in Canada from the province of Quebec on July 21, 2009, from Alberta on September 15, 2009 and from Ontario on October 13, 2009.
Vaccination
All the provinces and territories have started their vaccination campaigns except Nunavut which will start as of November 1, 2009.
Global information
Northern Hemisphere
Southern Hemisphere
FluWatch reports include data and information from five main sources: laboratory reports of positive influenza tests in Canada; sentinel physician reporting of influenza-like illness (ILI); provincial/territorial assessment of influenza activity based on various indicators, including laboratory surveillance, ILI reporting, school and work site absenteeism, and outbreaks; influenza-associated pediatric hospitalizations; WHO and other international reports of influenza activity.
The map shows influenza activity in the “influenza surveillance regions” † within each jurisdiction, as determined by the provincial/territorial epidemiologists.
Abbreviations: Newfoundland/Labrador (NL), Prince Edward Island (PE), New Brunswick (NB), Nova Scotia (NS), Quebec (QC), Ontario (ON), Manitoba (MB), Saskatchewan (SK), Alberta (AB), British Columbia (BC), Yukon (YT), Northwest Territories (NT), Nunavut (NU).
To share this page just click on the social network icon of your choice.